Official UK procurement notice
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") (NHS & healthcare)
What is being bought20 lots · detail below
Published requirement descriptionThis Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 39 bids on the busiest of 20 lots · 40 suppliers appointed
- Electronic auction
- yes
Lots and requirements (20)Procurement structure
20 lots · all with a published value · evaluation weights differ by lotLot #1Baclofen Intrathecal InjectionsAwardedRenewal ScotlandPublished value£48,856
Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #2Oxycodone InjectionsAwardedRenewal ScotlandPublished value£644,919
The Supply of Oxycodone Injections to NHS Scotland in a range of presentations.
The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #3Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For InjectionAwardedRenewal ScotlandPublished value£1,081,676
The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations.
The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #4Oxycodone Hydrochloride Prolonged Release TabletsAwardedRenewal ScotlandPublished value£231,183
The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #5Buprenorphine PatchesAwardedRenewal ScotlandPublished value£339,460
The supply of Buprenorphine Patches to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #6Fentanyl Tablets (Sublingual)AwardedRenewal ScotlandPublished value£307,639
The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #7Fentanyl Sf Tablet (Buccal)AwardedRenewal UKPublished value£3,843
Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #8Fentanyl Transdermal PatchAwardedRenewal UKPublished value£198,499
Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #9HydromorphoneAwardedRenewal UKPublished value£99,762
Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #10Lidocaine Chlorhexidine GelAwardedRenewal UKPublished value£1,470,863
Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #11Morphine Sulfate Modified-Release capsule (12Hr)AwardedRenewal UKPublished value£57,567
Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #12Morphine Sulfate Modified-Release capsule (24Hr)AwardedRenewal UKPublished value£918
The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #13Morphine Sulfate Modified-Release TabletAwardedRenewal UKPublished value£157,392
The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #14Oxycodone Hydrochloride CapsulesAwardedRenewal UKPublished value£127,100
The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Lot #15Propofol InjectionAwardedRenewal UKPublished value£3,611,463
The Supply of Propofol Injection to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #16Tramadol Hydrochloride Modified Release TabletsAwardedRenewal UKPublished value£32,765
The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #17Oxycodone Oral SolutionAwardedRenewal UKPublished value£257,688
The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #18Levobupivacaine (As Hydrochloride) Solution For InfusionAwardedRenewal ScotlandPublished value£393,905
The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations.
The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #19Supply to NHSS Pharmaceuticals "Specials" ServiceAwardedRenewal ScotlandPublished value£822,860
The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service.
The Authority has awarded each product line within this Lot to a single Framework Participant.
Lot #20All Other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesAwardedRenewal UKPublished value£25,579,509
Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations.
The Authority has awarded each product line within this Lot to a single Framework Participant.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Lots publish different evaluation splits; there is no single procedure weighting.
8 more lots publish their own split on the notice.
- Suitability
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a)Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b)Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c)All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d)Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
(e)Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark for Ethyl Chloride Spray and Lidocaine Gel
Minimum: (a)Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Techn…
- Price carries 80–95 points depending on the lot; most lots put it at 95 points.
- “NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease…” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 23 Aug 2023, 10:48 BST
- Last source update
- 7 Mar 2024, 16:47 GMT
- Award evaluation window
- 25 Sept 2023 – …
- FTS notice number
2024/S 000-007418- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03f631Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages
Publisher note: The estimated values referred to in Section II.1.5 and all Lots covers the twenty-four (24) months framework duration and the twenty-four (24) month extension period of the framework agreement. (SC Ref:758146)
How it was run
Official notice- Appointment period ends
- 25 Sept 2023, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 25 Sept 2023, 12:00 BST
Timeline
25 Sept 2023 → 7 Mar 2024 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown25 Sept 2023, 12:00 BST
- Bids opened25 Sept 2023, 12:00 BST
- Notice published7 Mar 2024, 16:47 GMT
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete7 Mar 2024, 16:47 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast20 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Lot 1 - Baclofen Intrathecal Injections
- Signed
- 13 Feb 2024
- Value
- £43,712
- Status
- active
Lot 10 - Lidocaine Chlorhexidine Gel
- Signed
- 13 Feb 2024
- Value
- £1,316,022
- Status
- active
Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)
- Signed
- 13 Feb 2024
- Value
- £60,959
- Status
- active
Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)
- Signed
- 13 Feb 2024
- Value
- £918
- Status
- active
Lot 13 - Morphine Sulfate Modified-Release Tablet
- Signed
- 13 Feb 2024
- Value
- £142,399
- Status
- active
Lot 14 - Oxycodone Hydrochloride Capsules
- Signed
- 13 Feb 2024
- Value
- £119,930
- Status
- active
Lot 15 - Propofol Injection
- Signed
- 13 Feb 2024
- Value
- £2,710,361
- Status
- active
Lot 16 - Tramadol Hydrochloride Modified Release Tablets
- Signed
- 13 Feb 2024
- Value
- £12,750
- Status
- active
Lot 17 - Oxycodone Oral Solution
- Signed
- 13 Feb 2024
- Value
- £283,005
- Status
- active
Lot 18 - Levobupivacaine (As Hydrochloride) Solution For Infusion
- Signed
- 13 Feb 2024
- Value
- £736,876
- Status
- active
Lot 19 - Supply to NHSS Pharmaceuticals "Specials" Service
- Signed
- 13 Feb 2024
- Value
- £1,025,580
- Status
- active
Lot 2 - Oxycodone Injections
- Signed
- 13 Feb 2024
- Value
- £459,978
- Status
- active
Lot 20 - All Other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
- Signed
- 13 Feb 2024
- Value
- £24,244,455
- Status
- active
Lot 3 - Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection
- Signed
- 13 Feb 2024
- Value
- £1,246,968
- Status
- active
Lot 4 - Oxycodone Hydrochloride Prolonged Release Tablets
- Signed
- 13 Feb 2024
- Value
- £196,895
- Status
- active
Lot 5 - Buprenorphine Patches
- Signed
- 13 Feb 2024
- Value
- £61,556
- Status
- active
Lot 6 - Fentanyl Tablets (Sublingual)
- Signed
- 13 Feb 2024
- Value
- £242,575
- Status
- active
Lot 7 - Fentanyl Sf Tablet (Buccal)
- Signed
- 13 Feb 2024
- Value
- £4,391
- Status
- active
Lot 8 - Fentanyl Transdermal Patch
- Signed
- 13 Feb 2024
- Value
- £143,286
- Status
- active
Lot 9 - Hydromorphone
- Signed
- 13 Feb 2024
- Value
- £28,665
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Baclofen Intrathecal Injections | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 2 · Oxycodone Injections | 7bids · 7 electronic · 7 from abroad | 0 | — | — |
| 3 · Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 4 · Oxycodone Hydrochloride Prolonged Release Tablets | 7bids · 7 electronic · 7 from abroad | 0 | — | — |
| 5 · Buprenorphine Patches | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
| 6 · Fentanyl Tablets (Sublingual) | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 7 · Fentanyl Sf Tablet (Buccal) | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 8 · Fentanyl Transdermal Patch | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 9 · Hydromorphone | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 10 · Lidocaine Chlorhexidine Gel | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 11 · Morphine Sulfate Modified-Release capsule (12Hr) | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 12 · Morphine Sulfate Modified-Release capsule (24Hr) | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 13 · Morphine Sulfate Modified-Release Tablet | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 14 · Oxycodone Hydrochloride Capsules | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 15 · Propofol Injection | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 16 · Tramadol Hydrochloride Modified Release Tablets | 3bids · 3 electronic · 3 from abroad | 0 | — | — |
| 17 · Oxycodone Oral Solution | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
| 18 · Levobupivacaine (As Hydrochloride) Solution For Infusion | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 19 · Supply to NHSS Pharmaceuticals "Specials" Service | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
| 20 · All Other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines | 39bids · 39 electronic · 39 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff CourtReview body
Framework contractors & participating bidders
43 commercial parties on the notice- Accord-UK LtdFramework contractor
- Aguettant LtdFramework contractor
- Arcadia Pharma Limited T/A Arcadia MedicalFramework contractor
- Aspen Pharmacare UK LimitedFramework contractor
- Aspire Pharma LtdFramework contractor
- B. Braun Medical LimitedFramework contractor
- B. Braun Medical LtdFramework contractor
- Baxter Healthcare LtdFramework contractor
- CST Pharma LtdFramework contractor
- Clinimed LimitedFramework contractor
Show 33 more suppliers
- Crescent Pharma LimitedFramework contractor
- DRUGSRUS LTDFramework contractor
- Day Lewis Medical LtdFramework contractor
- Ennogen Healthcare LtdFramework contractor
- Fresenius Kabi LtdFramework contractor
- GSK UK LimitedFramework contractor
- Gerot Lannach UK LtdFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Janssen Cilag LimitedFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- Kyowa Kirin International NewCo LtdFramework contractor
- Martindale PharmaFramework contractor
- Medreich PLCFramework contractor
- Mercury Pharmaceuticals LimitedFramework contractor
- Morningside Pharmaceuticals LimitedFramework contractor
- Napp PharmaceuticalsFramework contractor
- Neon HealthcareFramework contractor
- Novumgen LimitedFramework contractor
- Optimum Medical SolutionsFramework contractor
- Pfizer LtdFramework contractor
- Phoenix LabsFramework contractor
- Piramal CCFramework contractor
- Qdem PharmaceuticalsFramework contractor
- Rosemont Pharmaceuticals LtdFramework contractor
- SANDOZFramework contractor
- SandozFramework contractor
- Selective Supplies LtdFramework contractor
- Teva UK LimitedFramework contractor
- Teva UK LtdFramework contractor
- Thornton & RossFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- Wockhardt UK LimitedFramework contractor
- hameln pharma ltdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.